Reduction of serum interferon (IFN)-γ concentration and lupus development in NZBxNZWF1 mice by lactic dehydrogenase virus infection

Journal of Comparative Pathology

Volumn 125, Issue 4, 2001, Pages 285-291

  Hayashi, T ^a   Hasegawa, K ^a   Ohta, A ^a   Maeda, K ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKIN 4; LACTATE DEHYDROGENASE; NITROGEN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DISEASE MODEL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; IMMUNOGLOBULIN BLOOD LEVEL; INTERFERON INDUCTION; MORTALITY; MOUSE; MOUSE STRAIN; NONHUMAN; REGULATORY MECHANISM; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL; UREA NITROGEN BLOOD LEVEL; VIRUS INFECTION;

ANIMALIA; LACTATE DEHYDROGENASE-ELEVATING VIRUS;

EID: 0035666102     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcpa.2001.0507     Document Type: Article

References (23)

1. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains
2. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-1pr mice
3. Inhibition of interleukin synthesis and T cell proliferation by a monoclonal anti-Ia antibody
4. Cytokine production, serum levels and disease activity in systemic lupus erythematosus
5. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10: Interferon-γ-secreting cells in the peripheral blood
6. 2 and macrophage Ia antigen expression
7. 1 mice by persistent infection with lactic dehydrogenase virus: Possible involvement of superoxide anion as a progressive effector
8. Regulation of enzyme levels in the blood: Influence of environmental and genetic factors on enzyme clearance
9. 1 mice
10. Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus
11. In vivo treatment of (NZBxNZW)F1 lupus-like nephritis with monoclonal antibody to γ interferon
12. Suppression of development of glomerulonephritis in NZBxNZWF1 mice by persistent infection with lactic dehydrogenase virus: Relation between intercellular adhesion molecule-1 expression on endothelial cells and leucocyte accumulation in glomeruli
13. Development of lupus in BXSB mice is independent of IL-4
14. Pathogenesis of the glomerulonephritis of NZB/NZWF1 mice
15. Treatment of murine lupus with cDNA encoding IFN-gammaR/Fc
16. Dysregulation of T helper cell cytokines in autoimmune prone NZBxNZWF1 mice
17. Immune response in mice infected with lactic dehydrogenase virus. III. Antibody response to a T-dependent and a T-independent antigen during acute and chronic LDV infection
18. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
19. Roles of IL-4 and IL-12 in the development of lupus in NZB/W F1 mice
20. Inhibition of antibodies to nuclear antigen and to DNA in New Zealand mice infected with lactate dehydrogenase virus
21. Lactate dehydrogenase-elevating virus, equine arteritis virus and simian haemorrhagic fever virus: A new group of positive strand RNA viruses
22. Lactate dehydrogenase-elevating virus
23. Imbalance toward Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice